CA2913890C - BETA-CASEIN A2 AND PREVENTION OF BOWEL INFLAMMATION - Google Patents

BETA-CASEIN A2 AND PREVENTION OF BOWEL INFLAMMATION

Info

Publication number
CA2913890C
CA2913890C CA2913890A CA2913890A CA2913890C CA 2913890 C CA2913890 C CA 2913890C CA 2913890 A CA2913890 A CA 2913890A CA 2913890 A CA2913890 A CA 2913890A CA 2913890 C CA2913890 C CA 2913890C
Authority
CA
Canada
Prior art keywords
casein
beta
bowel
inflammation
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2913890A
Other languages
English (en)
French (fr)
Other versions
CA2913890A1 (en
Inventor
Andrew John Clarke
Malav Suchin Trivedi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
A2 Milk Co Ltd
Original Assignee
A2 Milk Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51989162&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2913890(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by A2 Milk Co Ltd filed Critical A2 Milk Co Ltd
Publication of CA2913890A1 publication Critical patent/CA2913890A1/en
Application granted granted Critical
Publication of CA2913890C publication Critical patent/CA2913890C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Animal Husbandry (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Confectionery (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2913890A 2013-05-31 2014-05-30 BETA-CASEIN A2 AND PREVENTION OF BOWEL INFLAMMATION Active CA2913890C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361829764P 2013-05-31 2013-05-31
US61/829,764 2013-05-31
PCT/NZ2014/000102 WO2014193248A1 (en) 2013-05-31 2014-05-30 Beta-casein a2 and prevention of inflammation of the bowel

Publications (2)

Publication Number Publication Date
CA2913890A1 CA2913890A1 (en) 2014-12-04
CA2913890C true CA2913890C (en) 2024-09-10

Family

ID=51989162

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2913890A Active CA2913890C (en) 2013-05-31 2014-05-30 BETA-CASEIN A2 AND PREVENTION OF BOWEL INFLAMMATION

Country Status (19)

Country Link
US (2) US20160113997A1 (enExample)
EP (2) EP3003485B1 (enExample)
JP (2) JP6867158B2 (enExample)
KR (2) KR102282972B1 (enExample)
CN (2) CN112316116A (enExample)
AU (2) AU2014271423B2 (enExample)
BR (1) BR112015029987A8 (enExample)
CA (1) CA2913890C (enExample)
CL (1) CL2015003507A1 (enExample)
DK (1) DK3003485T3 (enExample)
ES (1) ES2742306T3 (enExample)
IL (2) IL242833B (enExample)
MX (2) MX367794B (enExample)
MY (1) MY179497A (enExample)
PH (2) PH12015502674B1 (enExample)
RU (1) RU2669553C2 (enExample)
SG (2) SG11201509769QA (enExample)
WO (1) WO2014193248A1 (enExample)
ZA (1) ZA201508983B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112316116A (zh) * 2013-05-31 2021-02-05 艾尔牛奶有限公司 β-酪蛋白A2和肠炎症的预防
AU2014287862B2 (en) * 2013-07-12 2019-07-11 The A2 Milk Company Limited Beta-casein A2 and reducing or preventing symptoms of lactose intolerance
GB2519101A (en) * 2013-10-09 2015-04-15 Nicoventures Holdings Ltd Electronic vapour provision system
CN106455662A (zh) * 2014-06-03 2017-02-22 雅培制药有限公司 包含亲脂性活性成分的营养组合物
MX392728B (es) * 2015-05-22 2025-03-24 A2 Milk Co Ltd Beta-caseina a2 y su capacidad antioxidante.
WO2017003300A1 (en) * 2015-06-29 2017-01-05 The A2 Milk Company Limited A2 beta-casein and viscosity of milk products
WO2017171563A1 (en) 2016-03-30 2017-10-05 The A2 Milk Company Limited Beta-caseins and cognitive function
WO2018063008A1 (en) * 2016-09-30 2018-04-05 The A2 Milk Company Limited Beta-caseins and gut microbiota
EP3526201B1 (en) * 2016-10-14 2020-11-18 H. Hoffnabb-La Roche Ag Imidazole compounds as eaat3 inhibitors
NL2019906B1 (en) * 2017-11-14 2019-05-20 Ausnutria Hyproca B V Composition comprising a2 b-casein and a vegetable fat mixture
CN112205476A (zh) * 2019-07-11 2021-01-12 北京三元食品股份有限公司 β-酪蛋白A2、其组合物在促进双歧杆菌属增殖中的应用
WO2021003741A1 (zh) * 2019-07-11 2021-01-14 北京三元食品股份有限公司 β-酪蛋白A2、其组合物在促进双歧杆菌属增殖中的应用
CN115708530B (zh) * 2022-11-15 2024-08-09 北大荒完达山乳业股份有限公司 一种促进消化舒适性并稳定血糖的孕产妇配方奶粉及其制备方法
CN117322467A (zh) * 2023-10-11 2024-01-02 东北农业大学 A2β-酪蛋白在制备功能性食品中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE442585T1 (de) 1994-11-04 2009-09-15 A2 Corp Ltd Selektionsverfahren für nicht-diabetogene milch oder milchprodukte sowie hierdurch erfasste milch oder milchprodukte
NZ306584A (en) * 1995-05-16 2000-02-28 Corran Norman Stuart Mclachlan Milk or dairy products derived from animals and which are free of beta casein
WO1996036239A1 (en) 1995-05-16 1996-11-21 Corran Norman Stuart Mclachlan Food product and process
US6570060B2 (en) 1995-05-16 2003-05-27 Mclachlan Corran Norman Stuart Milk lacking β-casein A1
AU4266100A (en) * 1995-05-16 2000-10-12 Corran Norman Stuart Mclachlan Food product and process
EP1196047A4 (en) * 1999-06-29 2004-12-22 New Zealand Milk Inst Ltd MILK-BASED PROPHYLACTIC FOOD SUPPLEMENTS
NZ516712A (en) * 1999-06-29 2003-10-31 New Zealand Milk Inst Ltd Prophylactic dietary supplement based on milk
AU9037401A (en) 2000-09-08 2002-03-22 New Zealand Dairy Board Milk containing beta-casein with proline at position 67 does not aggravate neurological disorders
CA2444470A1 (en) * 2001-04-10 2002-10-24 Societe Des Produits Nestle S.A. Method and composition for prophylaxis of diabetes
US20060280802A1 (en) * 2002-10-04 2006-12-14 Campbell Julie H Therapeutic uses of beta-casein a2 and dietary supplement containing beta-casein a2
US7481127B2 (en) 2004-09-27 2009-01-27 Lester William T Continuously variable transmission using oscillating torque and one-way drives
KR20090083363A (ko) * 2006-10-06 2009-08-03 케리 그룹 서비스 인터내셔날 리미티드 우유 단백질 조성물 및 그 용도
US8871276B2 (en) * 2008-02-11 2014-10-28 Technion Research And Development Foundation Ltd. Beta-casein assemblies for mucosal delivery of therapeutic bioactive agents
TWI516269B (zh) * 2009-08-14 2016-01-11 禾伸堂生技股份有限公司 使用於炎症性腸疾病（ｉｂｄ）治療和預防之透明質酸混合物
CN112316116A (zh) * 2013-05-31 2021-02-05 艾尔牛奶有限公司 β-酪蛋白A2和肠炎症的预防
AU2014287862B2 (en) * 2013-07-12 2019-07-11 The A2 Milk Company Limited Beta-casein A2 and reducing or preventing symptoms of lactose intolerance

Also Published As

Publication number Publication date
DK3003485T3 (da) 2019-08-19
EP3003485A4 (en) 2016-11-30
EP3003485B1 (en) 2019-05-15
SG10201709509RA (en) 2017-12-28
IL242833B (en) 2019-07-31
CN105407971B (zh) 2020-11-17
JP7224242B2 (ja) 2023-02-17
WO2014193248A1 (en) 2014-12-04
KR20210094674A (ko) 2021-07-29
AU2014271423A1 (en) 2015-12-24
RU2015153113A (ru) 2017-07-05
AU2018274937A1 (en) 2019-01-03
JP2019165746A (ja) 2019-10-03
MX391963B (es) 2025-03-21
JP2016520611A (ja) 2016-07-14
HK1222362A1 (en) 2017-06-30
IL262302B (en) 2021-02-28
KR20160024884A (ko) 2016-03-07
AU2014271423B2 (en) 2018-12-20
IL262302A (en) 2018-11-29
MX367794B (es) 2019-09-06
KR102402455B1 (ko) 2022-05-25
RU2669553C2 (ru) 2018-10-12
ZA201508983B (en) 2017-11-29
EP3003485A1 (en) 2016-04-13
CA2913890A1 (en) 2014-12-04
MY179497A (en) 2020-11-09
RU2018131733A (ru) 2018-11-08
PH12015502674B1 (en) 2020-02-21
EP3542813A1 (en) 2019-09-25
BR112015029987A2 (pt) 2017-07-25
SG11201509769QA (en) 2015-12-30
CN112316116A (zh) 2021-02-05
PH12019550096A1 (en) 2020-02-10
JP6867158B2 (ja) 2021-04-28
MX2015016493A (es) 2016-08-18
ES2742306T3 (es) 2020-02-13
PH12015502674A1 (en) 2016-03-07
AU2018274937B2 (en) 2020-10-29
KR102282972B1 (ko) 2021-07-28
MX2019010594A (es) 2019-10-15
RU2018131733A3 (enExample) 2021-10-29
US11911439B2 (en) 2024-02-27
CN105407971A (zh) 2016-03-16
US20160113997A1 (en) 2016-04-28
US20200179485A1 (en) 2020-06-11
BR112015029987A8 (pt) 2021-12-07
NZ714912A (en) 2021-06-25
CL2015003507A1 (es) 2016-12-16

Similar Documents

Publication Publication Date Title
PH12019550096A1 (en) Beta-casein a2 and prevention of inflammation of the bowel
PH12016500511A1 (en) Selective grp94 inhibitors and uses thereof
IL238876A0 (en) Indoleamine 2,3-dioxygenase inhibitors, preparations containing them and their uses
PL3310764T3 (pl) Podstawione alkenylem 2,5-piperazynodiony i ich zastosowanie w kompozycjach do dostarczania środka do osobnika lub komórki
JO3343B1 (ar) أحماض 5- أمينوتتراهيدروكوينولين-2- كربوكسيليك جديدة واستخدامها
PH12016501702A1 (en) Pyrazole amide derivative
MX2015017636A (es) Mezclas fungicidas i que comprenden fungicidas de tipo estrobilurina.
MX2019009842A (es) Composicion solida que comprende sofosbuvir amorfo.
SI2739615T1 (sl) Fenil-3-aza-biciklo(3.1.0)heks-3-il-metanoni in njihova uporaba kot zdravilo
EP2958926A4 (en) Epidithiodioxopiperazine compound or its derivatives, and the use thereof
MY172040A (en) Synergistic dietary supplement for enhancing physical performance
GB2519982B (en) Fungicidal composition and the use thereof
MX2015013280A (es) Sonda fluorescente de zinc.
EP3187178A4 (en) Composition for reducing local fat and body weight, and pharmaceuticals and use thereof
IN2014DN11078A (enExample)
SG10201900598TA (en) Factor viii formulation
MX2019013642A (es) Compuestos, composiciones y metodos.
HUE067358T2 (hu) Szilárd ásványi anyagokon alapuló összetételek és az azokat tartalmazó orálisan dezintegráló készítmények
MX2016011413A (es) Formulaciones que comprenden xiloglucano polimérico como portador para agentes agronómicamente beneficiosos.
MX2017001737A (es) Vitamina b2 y sus usos.
EP3227293A4 (en) 6.7-cyclicmorphinan derivatives and use thereof
Mighton For the love of math
GB201904582D0 (en) All in one night safety leash
IN2013MU03582A (enExample)
TH169357A (th) เบต้า-คาเซอิน a2 และการป้องกันการอักเสบของลำไส้

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20190523

EEER Examination request

Effective date: 20190523

EEER Examination request

Effective date: 20190523

EEER Examination request

Effective date: 20190523

EEER Examination request

Effective date: 20190523

EEER Examination request

Effective date: 20190523

EEER Examination request

Effective date: 20190523

EEER Examination request

Effective date: 20190523